WEE1 and hepatocellular carcinoma: Moreover, recent research demonstrated that a combination of inhibitors of four protein kinases (RAS/RAF/MEK/ERK) with other pathway inhibitors that overexpressed in HCC could lead to satisfactory outcomes; overcoming the resistance mechanisms which are still unknown.